[Form 4/A] Innovex International, Inc. Amended Insider Trading Activity
Adam Anderson, Chief Executive Officer and a director of Innovex International, Inc. (INVX), reported a withholding of 13,067 shares to satisfy tax withholding on the release of restricted stock units on 09/08/2025 at a reported price of $16.82 per share. Following the transaction, Anderson beneficially owns 535,271 shares. The filing amends an earlier Form 4 to correct the withheld-share amount, which was originally reported as 12,833 shares; the amendment clarifies the correct withholding is 13,067 shares.
- Corrected disclosure restores accuracy by amending the originally misstated withheld-share amount from 12,833 to 13,067.
- Transaction is a routine tax-withholding on RSU release, not an open-market sale signaling divestment for liquidity needs.
- Insider beneficial ownership decreased by the withholding of 13,067 shares, executed at $16.82 per share, modestly reducing holdings to 535,271 shares.
Insights
TL;DR: Routine RSU tax-withholding reduced insider holdings modestly; amendment improves reporting accuracy.
The transaction is a non-cash, tax-withholding disposition tied to the vesting of restricted stock units, executed at $16.82 per share. With 13,067 shares withheld, Anderson's beneficial ownership is reported at 535,271 shares. The change from the originally reported 12,833 shares to 13,067 is clerical and the amendment restores filing accuracy, reducing regulatory risk from an incorrect disclosure. From an investor-impact perspective, this is a routine insider event with limited implications for company operations or capital structure.
TL;DR: Corrected Form 4 shows standard tax-withholding on RSU release; accurate disclosure supports governance compliance.
The amended filing addresses an earlier misstatement of withheld shares, moving from 12,833 to 13,067. Such corrections are important for transparency and SEC record integrity. The underlying action—withholding shares to meet tax obligations upon RSU release—is customary for executives and does not indicate discretionary selling for liquidity. The filing is compliant in form and timing, and the signature by an attorney-in-fact is properly executed.